Previous 10 | Next 10 |
Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Bank of America 2023 Animal Health Summit on Thursday, March 2, 2023. Jeff Simmons, president and CEO, and Todd Young, executive vice president and CFO, will represent the company and respond to questions from analysts at 4:40...
Summary Elanco Animal Health, an Eli Lilly spin-off, is the second-largest pure-play in the industry. On February 21, Elanco reported another largely disappointing year of restructuring, reorganization and poor financial performance, but there are a few signs of progress and improvement...
Image source: The Motley Fool. Elanco Animal Health (NYSE: ELAN) Q4 2022 Earnings Call Feb 21, 2023 , 8:00 a.m. ET Operator Continue reading For further details see: Elanco Animal Health (ELAN) Q4 2022 Earnings Call Transcript
Elanco Animal Health Inc. (ELAN) Q4 2022 Results Conference Call February 21, 2023 8:00 AM ET Company Participants Katy Grissom - Head of Investor Relations Jeff Simmons - President and Chief Executive Officer Todd Young - Chief Financial Officer Conference Call ...
Elanco Animal Health ( NYSE: ELAN ) Q4 top and bottom line beat estimates but the company's FY23 adjusted EPS outlook is seen below estimates. Q4 adjusted EPS declined -9.5% Y/Y to $0.19, while total revenue fell -11.2% Y/Y to $988M. However, both figures surpassed analysts expec...
Elanco press release ( NYSE: ELAN ): Q4 Non-GAAP EPS of $0.19 beats by $0.06 . Revenue of $988M (-11.0% Y/Y) beats by $7.06M . Adjusted EBITDA of $174 million or 17.6% of Revenue Full Year 2023 Guidance: Revenue of $4,280 to $4,400 million vs. consensus...
Fourth Quarter 2022 Financial Results: Revenue of $988 million Reported Net Loss of $54 million, Adjusted Net Income of $95 million Adjusted EBITDA of $174 million or 17.6% of Revenue Reported EPS of $(0.11), Adjusted EPS of $0.19 Net le...
Tim Bettington joins Elanco as EVP Corporate Strategy and Market Development Elanco Animal Health (NYSE: ELAN) announced today the appointment of Tim Bettington as the company’s executive vice president Corporate Strategy and Market Development. He will join Elanco’s execu...
Elanco ( NYSE: ELAN ) is scheduled to announce Q4 earnings results on Tuesday, February 21st, before market open. The consensus EPS Estimate is $0.13 (-38.1% Y/Y) and the consensus Revenue Estimate is $980.94M (-11.6% Y/Y). Over the last 2 years, ELAN has beaten EPS estimate...
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2022 financial results on Tuesday, February 21, 2023. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance. ...
News, Short Squeeze, Breakout and More Instantly...
Elanco Animal Health Incorporated Company Name:
ELAN Stock Symbol:
NYSE Market:
Elanco Animal Health Incorporated Website:
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / Feeding dairy cows Bovaer® (3-NOP), Elanco's newest feed ingredient , provides a scalable and credible way for dairy farmers to benefit from being good stewards of the environment by being financially rewarded for implementing on-farm sustaina...
Elanco Confirms Date and Conference Call for Second Quarter 2024 Financial Results Announcement PR Newswire GREENFIELD, Ind. , July 18, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2024 financial results on ...
SAN FRANCISCO, CA / ACCESSWIRE / July 17, 2024 / Hagens Berman urges Elanco Animal Health Incorporated (NYSE:ELAN) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/elan Contact the Firm Now: ELAN@hbsslaw.com 844-916-0895 ...